These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21726308)

  • 1. Methadone prescribing under supervised consumption on premises: a Scottish clinician's perspective on prescribing practice.
    Anthony GB; Matheson CI; Holland R; Bond C; Roberts K; Rae AM; Whitelaw E; Priyadarshi S
    Drug Alcohol Rev; 2012 May; 31(3):342-7. PubMed ID: 21726308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.
    Matheson C; Bond CM; Hickey F
    Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we prescribe heroin? A current Scottish debate.
    Gallagher J; McKeganey N
    Scott Med J; 2007 Nov; 52(4):2-4. PubMed ID: 18092628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment.
    Holland R; Matheson C; Anthony G; Roberts K; Priyardarshi S; Macrae A; Whitelaw E; Appavoo S; Bond C
    Drug Alcohol Rev; 2012 Jun; 31(4):483-91. PubMed ID: 22150819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of drug misuse: an 8-year follow-up survey of Scottish GPs.
    Matheson C; Porteous T; van Teijlingen E; Bond C
    Br J Gen Pract; 2010 Jul; 60(576):517-20. PubMed ID: 20594442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians.
    Coffin PO; Blaney S; Fuller C; Vadnai L; Miller S; Vlahov D
    Am J Drug Alcohol Abuse; 2006; 32(1):1-6. PubMed ID: 16450639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of methadone in drug-related deaths in the west of Scotland.
    Seymour A; Black M; Jay J; Cooper G; Weir C; Oliver J
    Addiction; 2003 Jul; 98(7):995-1002. PubMed ID: 12814505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Office-based methadone prescribing: acceptance by inner-city practitioners in New York.
    McNeely J; Drucker E; Hartel D; Tuchman E
    J Urban Health; 2000 Mar; 77(1):96-102. PubMed ID: 10741845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?
    Matheson C; Bond CM; Pitcairn J
    Addiction; 2002 Nov; 97(11):1405-11. PubMed ID: 12410781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified.
    Nielsen S; Dietze P; Dunlop A; Muhleisen P; Lee N; Taylor D
    Drug Alcohol Rev; 2007 Mar; 26(2):143-51. PubMed ID: 17364849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone prescribing is to be reviewed in Scotland as user numbers continue to rise.
    Christie B
    BMJ; 2012 Oct; 345():e6816. PubMed ID: 23047977
    [No Abstract]   [Full Text] [Related]  

  • 14. Deaths from drugs of abuse in Sheffield 1997-1999: what are the implications for GPs prescribing to heroin addicts?
    Oliver P; Keen J; Mathers N
    Fam Pract; 2002 Feb; 19(1):93-4. PubMed ID: 11818356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?
    Kurdyak P; Jacob B; Zaheer J; Fischer B
    Can Fam Physician; 2018 Feb; 64(2):e95-e103. PubMed ID: 29449263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
    Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
    Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective.
    Bell J
    Addiction; 2010 Sep; 105(9):1531-7. PubMed ID: 20626373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practice management of illicit drug users in Scotland: a national survey.
    Matheson C; Pitcairn J; Bond CM; van Teijlingen E; Ryan M
    Addiction; 2003 Jan; 98(1):119-26. PubMed ID: 12492763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.